Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
Objective:No standard postoperative adjuvant chemotherapy has ever been established in node-positive esophageal squamous cell carcinoma(ESCC).This is a study to explore the effect of postoperative paclitaxel(PTX)and cisplatin(DDP)in lymph node-positive,completely resected thoracic ESCC patients.Meth...
Saved in:
Published in | 中国癌症研究:英文版 no. 2; pp. 149 - 155 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2017
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!